Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16–26 years in Japan: a randomised, double-blind, placebo-controlled trial

The Lancet Infectious Diseases 2026

View at publisher
Authors: Koji Hisamoto, Masaki Yamanaka, Masayasu Nomura, Nobufumi Kanno, Anna R Giuliano, Keiko Wan, Yukako Fukao, Nobuyuki Oshima, Akira Wakana, Yoshiyuki Tanaka, Alain Luxembourg, Miyuki Sawata
DOI: 10.1016/s1473-3099(26)00291-4
Cited by: 1
References: 29

Fields of Study & Subjects

Cervical Cancer and HPV Research Immunotherapy and Immune Responses Virus-based gene therapy research

Publication details

Journal / source
The Lancet Infectious Diseases
Publisher
Elsevier BV
Publication date
1 August 2026
Language
EN